Delivery Order SPE2DB24D2003-SPE2DB25FXHS7

Award Date 5/14/25
Potential Completion Date 5/15/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 13, 2025, with a ceiling value of $1,214.16. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 14, 2025. This award is not associated with a...
This federal contract award, valued at $14,295.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product, with a performance period extending through May 8, 2025. The contract is a firm fixed-price, non-set-aside arrangement, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,484.70 for the supply of budesonide-formoterol 160-4.5 10.2GM medication. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through November 2024. The contract type is firm fixed price. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $2,921.57. The award is for the procurement of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of budesonide-formoterol 160-4.5 10.2GM medical products. The contract has a fixed-price, delivery order structure with a ceiling value of $1,769.78 and a completion date of July 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,289.97 delivery order contract is for the delivery of budesonide-formoterol 160-4.5 10.2 gram medication. The contract has a firm fixed price pricing type and an ultimate completion date of July 25, 2024. It is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Budesonide-Formoterol 80-4.5 10.2 GM, a pharmaceutical product, with a ceiling value of $3,540.00 and an ultimate completion date of November 21, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,760.00, is a delivery order for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,223.22, is a delivery order for the medication Budesonide-Formoterol 160-4.5 10.2GM. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,372.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 20, 2025. The contract is a Delivery Order under a Firm Fixed Price structure, and there was no set-aside designation used. AmerisourceBergen holds a significant...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXHS7
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM medication. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a firm fixed price ceiling value of $2,090.40. The award is a delivery order with a period of performance through May 15, 2025. This contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This positions Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/13/25, 10:48 AM